Philip Needleman
- Biochemistry top 0.01%
- Eicosanoids and Hypertension Pharmacology 87
- Pharmacology top 0.02%
- Inflammatory mediators and NSAID effects 97
-
- Antiplatelet Therapy and Cardiovascular Diseases 18
- Physiology top 0.2%
- Nitric Oxide and Endothelin Effects 34
- Nutrition and Dietetics top 0.2%
-
- Receptor Mechanisms and Signaling 30
- Peroxisome Proliferator-Activated Receptors 17
-
- Neuropeptides and Animal Physiology 20
-
- Electrolyte and hormonal disorders 16
- Co-authors
- Mark G. CurrieJaime L. MasferrerKaren SeibertAmiram RazBarbara A. JakschikAubrey R. MorrisonMark S. MinkesJ B Lefkowith
- Journals
- Prostaglandins (23 papers)Journal of Pharmacology and Experimental Therapeutics (22 papers)Journal of Clinical Investigation (21 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Philip Needleman
262 papers receiving 19.2k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Biochemistry 4.4k
- Pharmacology 6.1k
- Cardiology and Cardiovascular Medicine 5.7k
- Physiology 4.1k
- Nutrition and Dietetics 2.0k
Countries citing papers authored by Philip Needleman
This map shows the geographic impact of Philip Needleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Needleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Needleman more than expected).
Fields of papers citing papers by Philip Needleman
This network shows the impact of papers produced by Philip Needleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Needleman. The network helps show where Philip Needleman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip Needleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | From a Twinkle in the Eye to a Blockbuster Drug | 2001 | 4 |
| 2 | 1998 | 48 | |
| 3 | Discovery of a better aspirin. | 1995 | 21 |
| 4 | 1995 | 22 | |
| 5 | 1995 | 222 | |
| 6 | 1991 | 5 | |
| 7 | 1991 | 3 | |
| 8 | 1989 | 153 | |
| 9 | 1989 | 85 | |
| 10 | 1989 | 6 | |
| 11 | 1986 | 100 | |
| 12 | 1986 | 16 | |
| 13 | 1984 | 7 | |
| 14 | 1979 | 9 | |
| 15 | Lipases and prostaglandin biosynthesis. | 1978 | 18 |
| 16 | The synthesis and function of prostaglandins in the heart. | 1976 | 76 |
| 17 | 1974 | 95 | |
| 18 | 1972 | 32 | |
| 19 | 1969 | 19 | |
| 20 | 1966 | 28 |
About Philip Needleman
Philip Needleman is a scholar working on Biochemistry, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 263 papers that have together received 20.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (97 papers), Eicosanoids and Hypertension Pharmacology (87 papers), Nitric Oxide and Endothelin Effects (34 papers), Receptor Mechanisms and Signaling (30 papers), Neuropeptides and Animal Physiology (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Electrolyte and hormonal disorders (16 papers). The work is most often cited by research in Biochemistry (4.4k citations), Pharmacology (6.1k citations) and Cardiology and Cardiovascular Medicine (5.7k citations). Philip Needleman has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Mark G. Currie, Jaime L. Masferrer, Karen Seibert, Amiram Raz, Barbara A. Jakschik, Aubrey R. Morrison, Mark S. Minkes, J B Lefkowith, David M. Geller and A Raz. Their work appears in journals such as Prostaglandins, Journal of Pharmacology and Experimental Therapeutics, Journal of Clinical Investigation, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.